Asadi Mehdi, Fayazi Fahime, Iraji Aida, Sabourian Reyhaneh, Azizian Homa, Hajimahmoodi Mannan, Larijani Bagher, Mahdavi Mohammad, Amanlou Massoud
Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
BMC Chem. 2024 Apr 5;18(1):67. doi: 10.1186/s13065-024-01167-6.
A novel series of 4-nitrophenylpiperazine derivatives (4a-m) was designed and synthesized as potential tyrosinase inhibitors. Comprehensive characterization using H-NMR, C-NMR, CNH, and IR techniques was performed for all target compounds. Subsequently, the derivatives were evaluated for their inhibitory activity against tyrosinase. Among them, compound 4l, featuring an indole moiety at the N-1 position of the piperazine ring, exhibited a significant tyrosinase inhibitory effect with an IC value of 72.55 μM. Enzyme kinetics analysis revealed that 4l displayed mixed inhibition of the tyrosinase enzymatic reaction. Molecular docking was carried out in the enzyme's active site to further investigate the enzyme-inhibitor interactions. Based on the findings, compound 4l shows promise as a lead structure for the design of potent tyrosinase inhibitors. This study paves the way for the development of more effective tyrosinase inhibitors for potential applications in various fields.
设计并合成了一系列新型的4-硝基苯基哌嗪衍生物(4a - m)作为潜在的酪氨酸酶抑制剂。使用氢核磁共振(H-NMR)、碳核磁共振(C-NMR)、碳氢核磁共振(CNH)和红外(IR)技术对所有目标化合物进行了全面表征。随后,评估了这些衍生物对酪氨酸酶的抑制活性。其中,在哌嗪环N-1位带有吲哚部分的化合物4l表现出显著的酪氨酸酶抑制作用,其半数抑制浓度(IC)值为72.55 μM。酶动力学分析表明,4l对酪氨酸酶催化反应表现出混合型抑制作用。在酶的活性位点进行了分子对接,以进一步研究酶与抑制剂之间的相互作用。基于这些发现,化合物4l有望作为设计强效酪氨酸酶抑制剂的先导结构。该研究为开发更有效的酪氨酸酶抑制剂以用于各个领域的潜在应用铺平了道路。